US 12240902
Anti-TREM2 antibodies and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 12240902 (Anti-TREM2 antibodies and methods of use thereof) held by DENALI THERAPEUTICS INC. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61P, A61P25/28